Middle East & Africa Clinical Trial Supplies Market Size & Outlook
Middle East & Africa clinical trial supplies market, 2018-2030 (US$M)
Related Markets
MEA clinical trial supplies market highlights
- The MEA clinical trial supplies market generated a revenue of USD 34.8 million in 2023.
- The market is expected to grow at a CAGR of 4.3% from 2024 to 2030.
- In terms of segment, phase iii was the largest revenue generating phase in 2023.
- Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 34.8 million |
| Market revenue in 2030 | USD 46.7 million |
| Growth rate | 4.3% (CAGR from 2023 to 2030) |
| Largest segment | Phase iii |
| Fastest growing segment | Phase I |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Phase I, Phase II, Phase III |
| Key market players worldwide | Almac Group, Catalent Inc, Waldencast PLC Class A, PCI Technology, Sharp Corp, Thermo Fisher Scientific Inc, PAREXEL, Marken, KLIFO, BioCair |
Other key industry trends
- In terms of revenue, MEA region accounted for 1.3% of the global clinical trial supplies market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 704.4 million by 2030.
Phase iii was the largest segment with a revenue share of 53.16% in 2023. Horizon Databook has segmented the Middle East & Africa clinical trial supplies market based on phase i, phase ii, phase iii covering the revenue growth of each sub-segment from 2018 to 2030.
Middle East & Africa is one of the emerging markets for conducting clinical trials owing to increase in the demand for quality care, presence of a diverse population, and ease in patient recruitment. In addition, this region offers logistic benefits as European pharmaceutical companies are located in proximity to African regions than Latin America.
For American companies, sourcing patients and providing clinical supplies would be more economically beneficial in African regions over Asia. There are more than 12,000 active trials in African and Middle Eastern countries spearheaded by Kenya, Jordan, Uganda, Israel, and Egypt. The trend is expected to continue and is anticipated to attract players to this market, thereby contributing to the growth of clinical trial supplies market in the region.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Supplies Market Scope
Clinical Trial Supplies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
MEA clinical trial supplies market size, by country, 2018-2030 (US$M)
Middle East & Africa Clinical Trial Supplies Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
